secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0000950170-24-059543
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women’s Health stockholders approve all proposals at 2024 annual meeting
-------------------------------------------------------------------------------

- Elected six directors (Stefanie Cavanaugh, Celeste R. Fralick, Jannie Herchuk, Lynn O’Connor Vos, Nicole Sandford, Winfred Parnell) with >4.1M votes for each.
- Advisory say-on-pay approved: 4,189,574 for, 97,653 against, 1,752 abstain.
- Amended 2019 Stock Incentive Plan to increase authorized shares by 1,000,000 (total ISOs up to 3,000,000): 4,187,597 for, 98,942 against.
- Ratified BDO P.C. as auditor for FY2024: 7,992,912 for, 88,066 against, 12,358 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000095017024059543/0000950170-24-059543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000095017024059543/awh-20240513.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-059543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer